June 30 (Reuters) - A bipartisan group of U. lawmakers has opened national security investigations into whether drugmakers Merck and AbbVie have been involved in clinical trials conducted in China that helped fuel the communist country's military capability, according to letters seen by Reuters.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
328last 24h
2141last 7d
379● bullish (7d)
188● bearish (7d)
204publishers
Reuters43d agobearish
Exclusive-US House committee opens investigation into Merck, AbbVie China drug trialsStocktwits77d agoneutral
ABBV Stock Gains On Winning FDA Approval For Rare Blood Cancer DrugThe U.S. Food and Drug Administration (FDA) has approved pivekimab sunirine-pvzy (sold under the brand name Decnupaz), a highly targeted therapy for adults dealing with an ultra-rare and aggressive form of blood cancer.